This proposal is designed to determine the contribution of endothelial ACE to 20-hydoxyeicosatetraenoic acid (20-HETE)-mediated vascular dysfunction in hypertension. 20-HETE and its biosynthetic enzymes (CYP4) have been linked to the development of hypertension in genetic and experimental animal models and recently in humans. The biology of 20-HETE in the vasculature parallels that of Ang II. Like Ang II, 20-HETE is a vasoconstrictor and a mitogen. Ang II actions in vascular cells including superoxide/ROS stimulation, NF-kB activation and induction of inflammatory molecules, are also shared by 20-HETE as our recent studies suggest. Preliminary data further indicated that 20-HETE is a potent inducer of ACE in endothelial cells. Moreover, in models of 20-HETE-dependent hypertension vascular expression of ACE and AT1R is highly increased and treatment with ACE inhibitors or ATI R blockers prevents or reverses 20-HETE-dependent hypertension. The proposed studies set forth a novel paradigm and an attractive hypothesis arguing that excessive production of 20-HETE within the vasculature (androgen-induced hypertension) leads to hypertension via mechanisms that include the induction of endothelial ACE, thus perpetuating an increase in vascular Ang II which, in turn and together with 20-HETE, promotes renal vascular dysfunction. The proposed studies will investigate the relationship between 20-HETE and ACE in hypertension, elucidate cellular mechanisms underiying 20-HETE-mediated ACE induction and examine the contribution of 20-HETE-ACE to the hypertensive vascular phenotype. Our preliminary findings are exciting and potentially of great significance as they bring into being a new face to an old paradigm and suggest a feed fonward amplification of vascular dysfunction and hypertension brought about by 20-HETE induction of ACE. This together with the identification of 20-HETE as the mediator of androgen-driven hypertension raises important questions regarding gender-specific RAS-androgen interactions. The importance of elucidating and understanding the mechanisms underiying 20-HETE pro-hypertensive actions is underscored by recent reports linking CYP4 polymorphism and 20-HETE levels to hypertension in humans.

Public Health Relevance

Hypertension is a disease that leads to many manifestations including stroke, heart attack, and renal failure. It is recognized that men are at greater risk for hypertension than women and that androgen plays an important role. The mechanism of androgen-induced hypertension and susceptibility to cardiovascular morbidity is not completely known. Our studies identified 20-HETE as the mediator of androgen-induced hvpertension and have the potential to uncover novel therapeutic targets to treat hypertension.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL034300-29
Application #
8644832
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
29
Fiscal Year
2014
Total Cost
$449,552
Indirect Cost
$166,900
Name
New York Medical College
Department
Type
DUNS #
041907486
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Wu, Cheng-Chia; Gupta, Tanush; Garcia, Victor et al. (2014) 20-HETE and blood pressure regulation: clinical implications. Cardiol Rev 22:1-12
Abraham, Nader G; Sodhi, Komal; Silvis, Anne M et al. (2014) CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype. Hypertension 64:1352-61
Capdevila, Jorge H; Pidkovka, Nataliya; Mei, Shaojun et al. (2014) The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt. J Biol Chem 289:4377-86
Hinds Jr, Terry D; Sodhi, Komal; Meadows, Charles et al. (2014) Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity (Silver Spring) 22:705-12
Cheng, Jennifer; Edin, Matthew L; Hoopes, Samantha L et al. (2014) Vascular characterization of mice with endothelial expression of cytochrome P450 4F2. FASEB J 28:2915-31
Hao, Shoujin; Bellner, Lars; Zhao, Hong et al. (2014) NFAT5 is protective against ischemic acute kidney injury. Hypertension 63:e46-52
Chen, Li; Ackerman, Rachel; Saleh, Mohamed et al. (2014) 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo. J Pharmacol Exp Ther 348:442-51
Issan, Yossi; Kornowski, Ran; Aravot, Dan et al. (2014) Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress. PLoS One 9:e92246
Wang, Wen-Hui; Zhang, Chengbiao; Lin, Dao-Hong et al. (2014) Cyp2c44 epoxygenase in the collecting duct is essential for the high K+ intake-induced antihypertensive effect. Am J Physiol Renal Physiol 307:F453-60
Sodhi, K; Puri, N; Kim, D H et al. (2014) PPARýý binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats. Int J Obes (Lond) 38:456-65

Showing the most recent 10 out of 371 publications